PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q3–2026Q2) · Dividend yield is based on ₩0 per share · Prices as of the 2026-10-02 close
Chungdam Global runs a beauty and lifestyle distribution business centered on China and US livestream commerce and is diversifying through subsidiaries, but revenue has declined for three straight years and quarterly earnings swing widely, warranting caution in reading the trend.
2025 revenue came in at about KRW217.4 billion, down for a third consecutive year, with operating margin stuck in the 2-3% range.
Quarterly results swing sharply: an operating and net loss in Q4 2025, a sharp net profit jump in Q1 2026, then a net loss again in Q2 2026.
The company is diversifying through subsidiaries Bioviju (fillers/botulinum toxin), Idolstore (K-pop merchandise), Baishuko (luxury direct-purchase) and Creaceive (US TikTok advertising).
Operating cash flow has been negative for three straight years from 2023 to 2025, showing a persistent gap between reported profit and cash generation.
Intensifying competition and a consumption slowdown in China's livestream commerce market were cited as factors behind the Q1 2026 earnings decline.
Founded in 2017 and listed on KOSDAQ in June 2022, Chungdam Global is an e-commerce company specializing in the global distribution of beauty and lifestyle products.
Its core business consists of a B2B channel that sources domestic and international brands and supplies them to large Chinese platforms such as JD.com, Tmall and Walmart, and a D2C/S2C channel that sells directly to consumers by partnering with influencers (wanghong) on Douyin (TikTok China), Kuaishou and Xiaohongshu.
The company has built a big-data-driven platform called TDMS that automatically matches brands with influencers, and is pursuing a strategy of extending its Greater China capabilities into the US, European and Southeast Asian markets.
Its subsidiaries include Bioviju, which distributes medical aesthetics materials such as fillers and botulinum toxin; Baishuko, a luxury beauty and fashion reverse direct-purchase platform; Idolstore, which handles K-pop album and merchandise (MD) distribution; and Creaceive, which operates as an official TikTok advertising agency in the US.
Idolstore has also opened an offline store in Malaysia, expanding overseas offline channels. At the time of its IPO, the company cited Brand X Corporation, Silicon Two, and Revolve Group as comparable companies, illustrating the competitive landscape within the K-beauty and global e-commerce distribution sector.
Because the company is classified as an investment-type issuer not required to file a full business report, detailed disclosure such as segment revenue breakdowns is limited.
Overall, the company is in the process of expanding from a single cosmetics distributor into a diversified platform spanning beauty, medical aesthetics, entertainment merchandise and luxury commerce.
| Quarter | Revenue | Operating profit | Op. margin |
|---|---|---|---|
| 2025Q2 | ₩41.7B | ₩4.2B | 10.0% |
| 2025Q3 | ₩51.5B | ₩3.1B | 6.0% |
| 2025Q4 | ₩69.9B | -₩5.5B | −7.8% |
| 2026Q1 | ₩48.3B | ₩2.6B | 5.3% |
| 2026Q2 | ₩65.9B | ₩1.9B | 3.0% |
| Year | Revenue | Operating profit | Net income (parent) | Op. margin | ROE | Debt-to-equity |
|---|---|---|---|---|---|---|
| 2022 | ₩216.3B | ₩7.7B | ₩4.7B | 3.6% | 7.2% | 47.3% |
| 2023 | ₩237.8B | ₩5.7B | -₩1.9B | 2.4% | −3.1% | 74.4% |
| 2024 | ₩234.3B | ₩6.9B | ₩3.3B | 2.9% | 4.4% | 118.0% |
| 2025 | ₩217.4B | ₩5.4B | ₩3.1B | 2.5% | 3.6% | 77.0% |
Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-08-23
Annual revenue rose from about KRW216.3 billion in 2022 to KRW237.8 billion in 2023, then declined for three consecutive years to KRW234.3 billion in 2024 and KRW217.4 billion in 2025.
Operating profit fell from KRW7.7 billion in 2022 to KRW5.7 billion in 2023, rebounded to KRW6.9 billion in 2024, then dropped back to KRW5.4 billion in 2025, keeping operating margin in a narrow 2.4%-3.6% band.
The net income trajectory was more dramatic: attributable net profit of KRW4.7 billion in 2022 turned into a loss of about KRW1.9 billion in 2023, before returning to profits of KRW3.3 billion in 2024 and KRW3.1 billion in 2025, a slight year-on-year decline. Quarterly volatility stands out even more.
Revenue of KRW41.7 billion, operating profit of KRW4.2 billion and net profit of KRW0.4 billion in Q2 2025 gave way to a sharp jump in net profit to KRW3.9 billion in Q3 2025 on revenue of KRW51.5 billion and operating profit of KRW3.1 billion, but Q4 2025 swung to an operating loss of KRW5.5 billion and a net loss of KRW4.1 billion even as revenue rose to KRW69.9 billion.
In Q1 2026, revenue fell to KRW48.3 billion and operating profit slipped to KRW2.6 billion, yet net profit surged to KRW6.3 billion, showing a wide gap between operating and net results, while Q2 2026 posted revenue of KRW65.9 billion and an operating profit of KRW1.9 billion alongside a net loss of KRW2.0 billion.
This recurring divergence between operating and net income suggests non-operating items (such as equity-method gains, foreign exchange effects, or subsidiary-related items) are having a material quarter-to-quarter impact.
Attributable net profit summed over the most recent four quarters (Q3 2025 through Q2 2026) came to about KRW4.1 billion, a modest absolute figure even on an annualized basis.
On the balance sheet, owners' equity grew from KRW64.6 billion in 2022 to KRW86.4 billion in 2025, largely driven by non-controlling interests rising from KRW2.1 billion to KRW30.7 billion over the same period, likely reflecting listing and dilution effects at subsidiaries such as Bioviju.
Operating cash flow, positive at KRW1.6 billion in 2022, turned negative for three straight years — KRW-10.9 billion in 2023, KRW-8.6 billion in 2024 and KRW-21.8 billion in 2025 — pointing to a persistent gap between accounting profit and actual cash generation.
China's livestream commerce market has grown rapidly around influencer (wanghong) marketing, and Chungdam Global's beauty and lifestyle product distribution had been described as benefiting from this growth and expanding influencer marketing influence.
However, in Q1 2026 the company's core Beauty&Life distribution segment weakened as competition intensified within China's livestream commerce market and consumption slowed.
This suggests the market may be shifting from a growth phase toward one of intensifying competition among platforms and distributors vying for wanghong channels.
In terms of competitive positioning, the company cited Brand X Corporation, Silicon Two and Revolve Group as comparable companies at the time of its IPO, placing it among firms with similar K-beauty cross-border and overseas distribution business models.
High revenue dependence on a single country (China) and a single channel (such as JD.com) has been repeatedly flagged as a structural risk by industry observers, and business diversification is an ongoing effort to mitigate this.
Adjacent markets the company is expanding into — including US TikTok Shop and Western social commerce growth, the expanding K-pop merchandise market, and rising demand for medical aesthetics products such as fillers and botulinum toxin — are cited as potential diversification paths to reduce reliance on China.
The company has built the TDMS platform to automatically match brands with influencers, and is pursuing an expansion of its S2C (social commerce) business into the US, Europe and Southeast Asia by leveraging capabilities built up in Greater China livestream commerce.
In the US, subsidiary Creaceive operates as an official TikTok advertising agency and has stated plans to provide online commerce services in the US, Europe and the UK. Idolstore, which handles K-pop merchandise distribution, opened an offline store in Malaysia to target the Southeast Asian fandom market.
In medical aesthetics, subsidiary Bioviju continues to supply fillers and botulinum toxin products domestically and internationally on a B2B basis and is reportedly expanding into Europe and Southeast Asia.
However, as seen in the Q1 2026 results, intensifying competition and a consumption slowdown in China's livestream commerce market remain a near-term variable that could pressure earnings.
Whether the company's diversification efforts translate into an actual improvement in revenue mix and profitability, and whether the persistently negative operating cash flow trend improves, are likely to be the key points to watch going forward.
The current share price trades at a level not far from net asset value, suggesting the market is not currently assigning a large premium or discount relative to book value.
However, given that earnings over the most recent four quarters have swung sharply from one quarter to the next, any multiple calculated from a specific period's earnings level carries the risk of distortion from one-off factors in that period.
The company returned to profitability in 2024-2025 after a net loss in 2023, but the scale of profit still shows large quarter-to-quarter swings rather than a confirmed stable growth path. The company currently does not pay a dividend, placing dividend-related metrics on the lower end within the sector.
Compared with the high-growth e-commerce companies cited as peers at the time of its listing, there still appears to be a gap in earnings stability and cash flow generation.
PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-08-23
The company holds a mix of subsidiaries spanning Bioviju (fillers/botulinum toxin), Idolstore (K-pop merchandise), Baishuko (luxury direct-purchase) and Creaceive (US TikTok advertising). This can be viewed as an attempt to diversify revenue sources beyond a single cosmetics distribution structure. It is also expanding into overseas offline channels, as seen in Idolstore's opening of a store in Malaysia.
The company is pursuing a strategy to expand its S2C business into the US, Europe and Southeast Asia based on capabilities built in Greater China livestream commerce. Its US subsidiary Creaceive operates as an official TikTok advertising agency and has announced plans to enter the US, European and UK markets. There is a clear direction toward reducing reliance on a single market.
The company has built the TDMS platform, a big-data-based system that automatically matches brands with influencers. This is regarded as infrastructure that could enable more efficient partnership-building than a traditional, manpower-driven approach to matching wanghong influencers.
Revenue peaked at KRW237.8 billion in 2023 and has declined in both 2024 and 2025, falling to KRW217.4 billion in 2025. Operating margin has also remained stuck in the 2-3% range, making it difficult to find clear signs of improvement in either scale or profitability.
Operating and net results have diverged sharply quarter to quarter — an operating and net loss in Q4 2025, a net profit disproportionately larger than operating profit in Q1 2026, and a net loss despite positive operating profit in Q2 2026. This pattern can reduce the predictability of the company's earnings.
Operating cash flow has been negative for three consecutive years from 2023 through 2025. Cash has continued to flow out even in years when the company reported accounting profits, warranting scrutiny of earnings quality.
High revenue dependence on a single country (China) and a single channel (such as JD.com) has been a structural risk repeatedly flagged by industry observers. Intensifying competition and a consumption slowdown in China's livestream commerce market already weighed on Q1 2026 results.
Changes in China's consumption policy or platform regulations remain an external variable that could affect future earnings.
A recurring pattern of large gaps between operating and net income by quarter suggests results are heavily influenced by non-operating factors such as equity-method gains, foreign exchange effects, and subsidiary-related items. This structure implies that a net income surprise in one quarter may not necessarily carry through to the next.
Financial structure has been volatile, with the debt ratio rising from 47.3% in 2022 to 118.0% in 2024 before falling back to 77.0% in 2025.
Non-controlling interests surging from KRW2.1 billion in 2022 to KRW30.7 billion in 2025 suggests a relative reduction in the owners' share stemming from subsidiary listings or equity changes.
The possibility of further dilution to owners' attributable profit and capital through subsidiary listings or additional fundraising cannot be ruled out.
Q3 2026 (July-September) results are due to be disclosed, providing a chance to check changes in revenue mix (D2C/S2C versus B2B) and whether operating cash flow has improved.
Livestream commerce sales performance and influencer collaboration revenue during China's Singles' Day shopping season can offer a gauge of whether the company's China D2C channel is holding its competitive footing.
Ongoing monitoring of China's e-commerce and livestream commerce regulatory developments and local consumption indicators is needed to check whether the competitive intensification and consumption slowdown flagged in Q1 2026 is easing or persisting.
The annual audit report for fiscal year 2026 will provide confirmed figures on whether annual operating margin and operating cash flow actually improved.
Chungdam Global is in the process of diversifying its beauty and lifestyle distribution business, centered on China and US livestream commerce, by combining it with a disparate subsidiary portfolio spanning medical aesthetics, K-pop merchandise, luxury direct-purchase and US advertising services.
However, the confirmed financials show revenue declining for three straight years since 2023 and operating margin stuck in the 2-3% range, while quarterly results show a recurring, large divergence between operating and net income that lowers earnings predictability.
Operating cash flow remaining negative for three consecutive years from 2023 to 2025 also points to a gap between accounting profit and actual cash generation.
On the other hand, the TDMS platform, S2C expansion into the US, Europe and Southeast Asia, and individual growth stories at its subsidiaries can be viewed as positive elements supporting the direction of diversification.
Intensifying competition and a consumption slowdown in China's livestream commerce market, along with the risk of dependence on a single country and channel, remain key variables shaping the company's earnings.
Investors will want to watch upcoming quarters for changes in revenue mix, whether cash flow improves, and whether the gap between operating and net income persists.
Report written 2026-09-05 · Data as of 2026-09-04
This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.